QUBYX Receives FDA 510 (k) Clearance for PerfectLum 4.0 Software & 5K Apple iMac Bundle

WILMINGTON, Del., July 14, 2020 /PRNewswire/ — Qubyx Software Technologies, is proud to announce the Qubyx PerfectLum 4.0 Software & 27-inch Retina 5K Apple iMac display bundle has received FDA 501(k) clearance as a medical device. This is the first Apple iMac diagnostic medical display to be offered to healthcare institutions. 

Qubyx PerfectLum 4 Medical Display Calibration and QA Software
PerfectLum 4.0 by QUBYX is a professional calibration and quality assurance software that enhances the performance of any monitor per the key standards of medical imaging. It features DICOM-compliance and professional standards, including New York Primary Diagnostic Monitor Guideline (NYPDM), AAPM TG18, DIN 6868-57, DIN 6868-157, JESRA X-0093, IEC 62563-1 and ACR.

“QUBYX proves again, that it is has the capability to enhance any type of displays, medical, laptops, commercial significantly and can help to reduce the cost for medical equipment.”

Shareden Imaging Sales and Software Support
Shareden Imaging Solutions (SIS), the North American distributor and technical support provider for Qubyx PerfectLum 4 Software solutions, will distribute, resell and support the new PerfectLum Software and Apple iMac Diagnostic Medical Display bundle.

According to R. Manielle Johnson, Founder and Technology Director of Shareden Imaging Solutions, “Qubyx obtaining FDA 510(k) for the Apple iMac and PerfectLum 4 bundle was a natural progression for this combination.  PerfectLum Suite has been used with iMacs for medical imaging by discerning health systems and progressive radiologists for many years.”

The 27-inch Retina 5K Apple iMac display with Qubyx PerfectLum 4.0 displays and views medical images for review and analysis. With the bundled PerfectLum application, the iMac calibrates to DICOM GSDF and verifies its conformance. The 27-inch iMac has a 5K Retina display with one billion colors, 500 nits of brightness, and a resolution of 5120 x 2880, providing balance and precision for superior image quality. 

Apple iMac Display/Processor Features
Retina 5K Display:
•  27-inch (diagonal) Retina 5K display
•  5120–by–2880 resolution with support for one billion colors
•  500 nits brightness
•  Wide color (P3)

Processors:
•  3.0GHz
     •  3.0GHz 6–core Intel Core i5 (Turbo Boost up to 4.1GHz)
•  3.1GHz
     •  3.1GHz 6–core Intel Core i5 (Turbo Boost up to 4.3GHz)
     •  Configurable to 3.6GHz 8-core Intel Core i9 (Turbo Boost up to 5.0GHz)
•  3.7GHz
     •  3.7GHz 6–core Intel Core i5 (Turbo Boost up to 4.6GHz)
     •  Configurable to 3.6GHz 8-core Intel Core i9 (Turbo Boost up to 5.0GHz)

The waitlist for the PerfectLum 4 & iMac bundle will be open soon.

About QUBYX
QUBYX is a software/hardware manufacturer providing new dimensions of image quality in the medical imaging industry and display calibration field.

For more information, visit: https://qubyx.com

Press Contact:
Marc Leppla CTO
info@qubyx.com
QUBYX Medical Solutions Inc.

About Shareden Imaging Solutions
Shareden Imaging Solutions (SIS) is a privately held medical imaging technology consulting firm. SIS provides exceptional imaging solutions designed to enable healthcare clients of all sizes to comply with the highest medical imaging standards.

Headquartered in Novi, Michigan, SIS is a North American distributor and technical support provider for Qubyx PerfectLum Software Suite.

SIS specializes in read-at-home solutions. The company offers turnkey and price competitive solutions for this target market.  For more information, visit: www.sharedenimaging.com

Contact:
Deb Kelley
Shareden Imaging Solutions, LLC
(866) 651-5005 Ext. 2
243373@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/qubyx-receives-fda-510-k-clearance-for-perfectlum-4-0-software–5k-apple-imac-bundle-301092437.html

SOURCE Shareden Imaging Solutions

Staff

Recent Posts

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

45 minutes ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

 Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…

3 hours ago

Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…

3 hours ago